Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics

被引:14
|
作者
Sauermann, R
Gattringer, R
Graninger, W
Buxbaum, A
Georgopoulos, A
机构
[1] Univ Vienna, Vienna Gen Hosp, Dept Internal Med 1, Div Infect Dis & Chemotherapy, A-1090 Vienna, Austria
[2] Univ Vienna, Vienna Gen Hosp, Dept Internal Med 4, Div Pulm, A-1090 Vienna, Austria
关键词
S; pyogenes; Bavaria; susceptibility; macrolide resistance; phenotypes;
D O I
10.1093/jac/dkg039
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The purpose of the present study was to determine the antimicrobial resistance among Streptococcus pyogenes in Bavaria, Germany. Five hundred and forty isolates of S. pyogenes were collected from patients with tonsillopharyngitis. Of these, 425 isolates were obtained from children and 115 from adult patients. All isolates were tested for susceptibility to macrolides, clindamycin, penicillin and 10 other commonly prescribed antimicrobial agents, using broth microdilution tests. All isolates were fully susceptible to penicillin, amoxicillin and cephalosporins; 16.1% of the isolates were resistant to tetracycline. MIC90 values of erythromycin, clarithromycin, azithromycin and josamycin were 16, 4, 16 and 0.5 mg/L. The overall resistance rate of S. pyogenes to erythromycin, clarithromycin and azithromycin was 13.3%. All isolates resistant to erythromycin were also resistant to clarithromycin and azithromycin, and vice versa. Erythromycin resistance rates were higher in adult patients (19.1%) than in children (11.8%). The resistance rate to josamycin was only 1.5%, a value similar to that of clindamycin (1.1%). Among the 72 erythromycin-resistant isolates the M phenotype of macrolide resistance predominated (78%), while percentages of cMLS(B) (8%) and iMLS(B) (14%) phenotypes were low. Of the iMLS(B) strains (n = 10), the majority were of the subtype C (n = 8). The M phenotype was associated with a low, and the iMLS(B)-C phenotype with a high, rate of resistance to tetracycline. Conclusively, present data point to rising macrolide resistance among S. pyogenes in Bavaria.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 50 条
  • [1] Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures
    Ergin, A
    Ercis, S
    Hasçelik, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (01) : 139 - 141
  • [2] Prevalence of Macrolide Resistance Among Group A Streptococci Isolated from Pharyngotonsillitis
    Wajima, Takeaki
    Chiba, Naoko
    Morozumi, Miyuki
    Shouji, Michi
    Sunaoshi, Katsuhiko
    Sugita, Kayoko
    Tajima, Takeshi
    Ubukata, Kimiko
    MICROBIAL DRUG RESISTANCE, 2014, 20 (05) : 431 - 435
  • [3] MACROLIDE AND CLINDAMYCIN RESISTANCE IN GROUP A STREPTOCOCCI ISOLATED FROM CHILDREN WITH PHARYNGITIS
    DeMuri, Gregory P.
    Sterkel, Alana K.
    Kubica, Phillip A.
    Duster, Megan N.
    Reed, Kurt D.
    Wald, Ellen R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (03) : 342 - 344
  • [4] Macrolide resistance in group A streptococci
    Savoia, D
    Avanzini, C
    Bosio, K
    Volpe, G
    Carpi, D
    Dotti, G
    Zucca, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) : 41 - 47
  • [5] Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children
    Ioannidou, S
    Tassios, PT
    Kotsovili-Tseleni, A
    Foustoukou, M
    Legakis, NJ
    Vatopoulos, A
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (03) : 195 - 201
  • [6] The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group a streptococci in Finland
    Seppala, H
    Klaukka, T
    VuopioVarkila, J
    Muotiala, A
    Helenius, H
    Lager, K
    Huovinen, P
    Kontiainen, S
    Eskola, J
    Korpela, J
    KostialaThompson, A
    Sarkkinen, H
    Schauman, K
    Sivonen, A
    Vaara, M
    Eerola, E
    Hiekkaniemi, H
    Jarvinen, H
    Klossner, ML
    Lehtonen, OP
    Meurman, O
    Oinonen, S
    Katila, ML
    Karkkainen, P
    Liimatainen, O
    Vuento, R
    Nissinen, A
    Hirvonen, P
    Kauppinen, M
    Kirsi, O
    Larinkari, U
    Ahonen, E
    Herva, E
    Jagerroos, H
    Koskela, M
    Lantto, K
    Ruuska, P
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07): : 441 - 446
  • [7] Mechanisms of macrolide resistance in clinical group B streptococci isolated in France
    Fitoussi, F
    Loukil, C
    Gros, I
    Clermont, O
    Mariani, P
    Bonacorsi, S
    Le Thomas, I
    Deforche, D
    Bingen, E
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1889 - 1891
  • [8] Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora
    Seppälä, H
    Haanperä, M
    Al-Juhaish, M
    Järvinen, H
    Jalava, J
    Huovinen, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) : 636 - 644
  • [9] Antibiotic susceptibility and molecular mechanisms of macrolide resistance in streptococci isolated from adult cystic fibrosis patients
    Thornton, Christina S.
    Grinwis, Margot E.
    Sibley, Christopher D.
    Parkins, Michael D.
    Rabin, Harvey R.
    Surette, Michael G.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 64 : 1375 - 1386
  • [10] Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea
    Uh, Y
    Shin, DH
    Jang, IH
    Hwang, GY
    Lee, MK
    Yoon, KJ
    Kim, HY
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (06) : 1095 - 1097